Bird (e.g., Chicken, Etc.) Patents (Class 800/19)
-
Patent number: 7521591Abstract: This invention provides eggs which contain exogenous proteins. The invention further provides transgenic chickens which express exogenous sequences in their oviducts, and vectors and methods for the stable introduction of exogenous nucleic acid sequences into the genome of a bird for expressing said exogenous sequences to alter the phenotype of the bird or to produce desired proteins.Type: GrantFiled: October 28, 2003Date of Patent: April 21, 2009Assignees: Synageva BioPharm Corp., University of Georgia Research FoundationInventors: Robert D. Ivarie, Alex J. Harvey, Julie A. Morris, Guodong Liu
-
Publication number: 20090098134Abstract: The invention relates to transgenic animals lacking endogenous Ig and capable of producing transgenic antibodies, as well as methods of making the same. The invention further relates to methods for producing transgenic antibodies in such animals, and transgenic antibodies so produced.Type: ApplicationFiled: May 30, 2008Publication date: April 16, 2009Applicant: OMT, Inc.Inventor: Roland BUELOW
-
Publication number: 20090100532Abstract: Provided herein are transgenic non-human animals having a transgene encoding a variant nicotinic acetylcholine receptor (nAChR) subunit, wherein the variant nAChR subunit is selected from the group consisting of ?6, ?5, and ?2. The transgenic animals display a modified phenotype that includes nicotinic hypersensitivity. Also provided are methods of generating the invention transgenic animals. Further provided are methods for screening a candidate agent for the ability to modulate nicotine-mediated behavior in the invention transgenic animals.Type: ApplicationFiled: September 24, 2008Publication date: April 16, 2009Applicant: CALIFORNIA INSTITUTE OF TECHNOLOGYInventors: Ryan Drenan, Henry A. Lester
-
Publication number: 20090083872Abstract: Methods for preparing recombinant proteins, such as antibodies, in eggs are described. The method offers advantages over existing systems for preparing recombinant proteins including high yield, low cost and compatibility with animal protection regulations. In addition, since eggs are edible food sources the recombinant protein does not have to be isolated from the egg.Type: ApplicationFiled: April 7, 2008Publication date: March 26, 2009Inventors: Robert J. Etches, Mansoor Mohammed, Sherie Morrison, Letitia A. Wims, Kham M. Trinh, Alan G. Wildeman
-
Publication number: 20090083871Abstract: A transgenic chicken is disclosed having disrupted endogenous immunoglobulin production. In one embodiment, a targeting construct is stably integrated into the genome of the chicken by homologous recombination in embryonic stem cells, and injection of the engineered embryonic stem cells into recipient embryos, thereby knocking out the endogenous immunoglobulin gene locus in resulting animals. The targeted disruption of the locus in embryonic stem cells is particularly useful in combination with the insertion of genetic elements encoding exogenous immunoglobulin molecules. After these chickens are cross-bred, a line of chickens is produced that has a reduction of endogenous immunoglobulin molecule production.Type: ApplicationFiled: October 24, 2007Publication date: March 26, 2009Inventors: Robert J. Etches, Robert M. Kay, Lei Zhu
-
Patent number: 7507873Abstract: Transgenic avians having a recombinant ovomucoid gene expression controlling region operably linked to one or more useful amino acid coding sequences.Type: GrantFiled: January 4, 2007Date of Patent: March 24, 2009Assignee: AviGenics, Inc.Inventors: Alex J. Harvey, Markley C. Leavitt, Youliang Wang
-
Publication number: 20090064351Abstract: The present invention has its object to provide a transgenic bird producing erythropoietin at high concentration levels as well as a method for constructing the same. The present invention provides a G0 transgenic chimera bird as obtained by incubating a fertilized avian egg, infecting the early embryo formed after egg laying, except for the blastoderm stage immediately following egg laying, with a replication-deficient retroviral vector containing a foreign erythropoietin gene and allowing the embryo to hatch.Type: ApplicationFiled: February 24, 2006Publication date: March 5, 2009Applicant: Kaneka CorporationInventors: Shinji Iijima, Masamichi Kamihira, Kenichi Nishijima
-
Publication number: 20090053210Abstract: The present invention describes transgenic animals with human(ized) immunoglobulin loci and transgenes encoding human(ized) Ig? and/or Ig? sequences. Of particular interest are animals with transgenic heavy and light chain immunoglobulin loci capable of producing a diversified human(ized) antibody repertoire that have their endogenous production of Ig and/or endogenous Ig? and/or Ig? sequences suppressed. Simultaneous expression of human(ized) immunoglobulin and human(ized) Ig? and/or Ig? results in normal B-cell development, affinity maturation and efficient expression of human(ized) antibodies.Type: ApplicationFiled: August 27, 2007Publication date: February 26, 2009Inventor: Roland Buelow
-
Patent number: 7481179Abstract: The present invention relates to the field of avian reproduction. In particular, the present invention provides a method of activating an egg in a shell. The invention also provides a method of activating an egg in a shell, whereby a live chick is hatched.Type: GrantFiled: June 29, 2007Date of Patent: January 27, 2009Inventors: Tim Cantrell, Andrew Wooten
-
Patent number: 7476776Abstract: The present invention relates to a method for improving the germline transmission efficiency of avian primordial germ cells (PGCs), and methods for producing avian chimeras and transgenic using it. The present method comprises the steps of (a) isolating primordial germ cells (PGCs) from an avian embryonic gonad; and (b) culturing said PGCs in vitro for at least 5 days. According to the present method, the germline transmission efficiency of PGCs can be dramatically improved in a feasible manner.Type: GrantFiled: April 21, 2004Date of Patent: January 13, 2009Assignees: Seoul National University Industry Foundation, Avicore Biotechnology Institute Inc., Hanmi Pharm. Co. Ltd.Inventors: Jae Yong Han, Tae Sub Park, Yeong Ho Hong, Se Chang Kwon
-
Publication number: 20090007284Abstract: A method of producing a transgenic cell comprising introducing into a cell a non-primate lentiviral expression vector comprising a nucleotide of interest (NOI). Also described is a method of producing a transgenic cell comprising introducing into a cell a lentiviral expression vector comprising a NOI capable of generating an antisense oligonucleotide, a ribozyme, an siRNA, a short hairpin RNA, a micro-RNA or a group 1 intron. Also described is a viral vector comprising a first nucleotide sequence, wherein said first nucleotide sequence comprises: (a) a second nucleotide sequence comprising an aptazyme; and (b) a third nucleotide sequence capable of generating a polynucleotide; wherein (a) and (b) are operably linked and wherein the aptazyme is activatable to cleave a transcript of the first nucleotide sequence such that said polynucleotide is generated.Type: ApplicationFiled: January 14, 2008Publication date: January 1, 2009Inventors: Philippa Radcliffe, Kyriacos Mitrophanous, Michael Themis
-
Publication number: 20080235815Abstract: Methods and compositions for the administration of transposon-based vectors to the reproductive organs of animals and the creation of transgenic animals. Preferred methods involve administration of the transposon-based vectors to the lumen of the oviduct of an avian, expression of a vector derived transgene in the avian, and deposition of the resultant polypeptide in an egg. This invention allows for large amounts of protein to be deposited in the egg.Type: ApplicationFiled: October 31, 2007Publication date: September 25, 2008Inventors: Richard K. Cooper, William C. Fioretti, Gary G. Cadd
-
Publication number: 20080235813Abstract: Administration of modified transposon-based vectors has been used to achieve stable incorporation of exogenous genes into animals. These transgenic animals produce transgenic progeny. Further, these transgenic animals produce large quantities of desired molecules encoded by the transgene. Transgenic egg-laying animals produce large quantities of desired molecules encoded by the transgene and deposit these molecules in the egg.Type: ApplicationFiled: October 31, 2007Publication date: September 25, 2008Inventors: Richard K. Cooper, Gary G. Cadd, William C. Fioretti, Kenneth F. De Boer
-
Publication number: 20080222743Abstract: The invention relates to transgenic avians whose genome contains nucleotide sequences which encode therapeutic polynucleotides that correspond to one or more certain sequences in the genome of an avian pathogen.Type: ApplicationFiled: May 1, 2007Publication date: September 11, 2008Inventors: Leandro Christmann, Jeffrey C. Rapp
-
Patent number: 7423194Abstract: This invention is in the field of neurology. Specifically, the invention relates to the discovery and characterization of molecular components that play a role in neuronal demyelination or remyelination. In addition, the invention relates to the generation of an animal model that exhibits hypomyelination. The compositions and methods embodied in the present invention are particularly useful for drug screening and/or treatment of demyelination disorders.Type: GrantFiled: May 9, 2006Date of Patent: September 9, 2008Assignee: University of ChicagoInventors: Brian Popko, Wensheng Lin
-
Publication number: 20080213426Abstract: A transgenic non-human animal of the species selected from the group consisting of avian, bovine, ovine and porcine having a transgene which results in disrupting the production of and/or activity of growth differentiation factor-8 (GDF-8) chromosomally integrated into the germ cells of the animal is provided. Also provided are methods for making such animals, and methods of treating animals, including humans, with antibodies or antisense directed to GDF-8. The animals so treated are characterized by increased muscle tissue and bone content.Type: ApplicationFiled: April 15, 2008Publication date: September 4, 2008Inventors: Se-Jin Lee, Alexandria C. McPherron
-
Publication number: 20080184380Abstract: The invention provides anovel approach for the suppression of endogenous antibody expression in non-human transgenic animals genetically engineered to express one or several human or humanized immunoglobulin transloci. Endogenous immunoglobulin expression in transgenic non-human animals is suppressed by selective expression of a suicide gene like a toxin only in B-cells expressing endogenous immunoglobulin but not in B-cells expressing human(ized) immunoglobulins. This method allows the dominant expression of transloci coding for humanized or human antibodies in the blood, milk and eggs of transgenic animals.Type: ApplicationFiled: October 21, 2005Publication date: July 31, 2008Applicant: THERAPEUTIC HUMAN POLYCLONALS INC.Inventors: Roland Buelow, Josef Platzer
-
Patent number: 7381712Abstract: The present invention provides for methods of producing transgenic avians which may include delivering a heterologous nucleic acid to oviduct tissue of an avian wherein the nucleic acid enters a cell of the oviduct tissue and is expressed.Type: GrantFiled: May 10, 2004Date of Patent: June 3, 2008Assignee: AviGenics, Inc.Inventors: Leandro Christmann, Markley C. Leavitt, Dawn M. Eberhardt, Timalynn M. Matthews
-
Publication number: 20080124792Abstract: The invention includes hybrid promoters containing an LTR component and a promoter component, transgenic avians containing the hybrid promoters in their genome and methods of making the transgenic avians.Type: ApplicationFiled: July 24, 2007Publication date: May 29, 2008Inventor: Alex J. Harvey
-
Patent number: 7375258Abstract: The present invention provides novel isolated nucleic acids that comprise an avian nucleic acid sequence comprising a ovomucoid gene expression control region. The ovomucoid promoter region of the present invention will allow expression of an operably linked heterologous nucleic acid insert in a transfected avian cell such as, for example, an oviduct cell. The isolated avian ovomucoid of the present invention may be operably linked with a selected nucleic acid insert, wherein the nucleic acid insert encodes a polypeptide desired to be expressed in a transfected cell. The recombinant DNA of the present invention may further comprise a polyadenylation signal sequence. The present invention further includes expression vectors comprising an isolated avian ovomucoid gene expression control region of the present invention, and transfected cells and transgenic avians comprising the expression vectors.Type: GrantFiled: December 2, 2002Date of Patent: May 20, 2008Assignee: AviGenics, Inc.Inventors: Alex J. Harvey, Youliang Wang
-
Patent number: 7355092Abstract: Genetic vaccine which comprises plasmid(s) containing genes coding for antigens of enterotoxigenic Escherichia coli (ETEC) strains is disclosed. Additionally, plasmids may consist of multiple copies of the same antigen (i.e. K88 or K99 fimbrial antigen) or multiple antigens (ie. K88 and K99 fimbrial antigens) and genetic adjuvants such as cytokines (IL-2, IL-4 & GM-CSF), costimulatory molecules (CD80 & CD86) or chemokines or immunostimulatory sequences. A method for isolating antibodies from chicken egg yolk for passive immunization of animals, as well as humans to control diarrhoeal diseases using the genetic vaccines is also disclosed.Type: GrantFiled: December 27, 2000Date of Patent: April 8, 2008Inventors: Ronald Marquardt, Suk-Hyeon Cho, Peter Loewen, Srinivasa Madhyastha
-
Publication number: 20080060087Abstract: In one aspect, the present invention provides a genetically modified cell or non-human organism comprising such cells comprising modified genetic material which when expressed produces a polypeptide co-expressed with a reporter molecule and wherein the polypeptide is associated with terminal differentiation of a haematopoietic cell. Preferably, the genetic material gene is a Blimp allele or a part, fragment or functional form thereof. Furthermore, the identification of the reporter molecule in B-cell lineage cells indicates that such cells are committed to differentiate or have differentiated into ASC. Alternatively, reporter molecule activity in cells of a T cell lineage indicates that these cells are activated. Thus, as described herein, the presence of Blimp in a lymphocyte indicates that the cell is terminally differentiated or is committed to terminal differentiation. Exemplary T-cells include CD4+ T-cells and CD8+ T-cells and exemplary B-cells are ASC.Type: ApplicationFiled: February 11, 2005Publication date: March 6, 2008Inventors: Axel Kallies, Jhagvaral Hasbold, David Tarlington, Lynn Corcoran, Philip Desmond Hodgkin, Stephen Laurence Nutt
-
Patent number: 7339090Abstract: The present invention provides for microinjection devices comprising a needle and a viewing instrument wherein the viewing instrument provides magnified viewing of an object to an operator from an angle other than a right angle to the object.Type: GrantFiled: June 23, 2005Date of Patent: March 4, 2008Assignee: AviGenics, Inc.Inventor: Leandro Christmann
-
Patent number: 7323619Abstract: The present invention relates to methods for producing transgenic animals, particularly transgenic birds and fish, using retroviral constructs engineered to carry the transgene(s) of interest.Type: GrantFiled: September 13, 2002Date of Patent: January 29, 2008Assignee: California Institute of TechnologyInventors: David Baltimore, Elizabeth J. Hong, Carlos Lois-Caballe, Shirley Pease
-
Patent number: 7323618Abstract: Transgenes encoding exogenous proteins are stably integrated into embryonic stem cells and are present in the somatic tissue of transgenic or chimeric birds. The transgenes encode exogenous proteins and are expressed in any of endodermal, ectodermal, mesodermal, or extra embryonic tissue. Tissue specificity is provided by selecting the content of the transgene accordingly. Transgenic birds whose genome is comprised of trangene derived exogenous DNA express exogenous proteins with tissue specificity, and specifically express exogenous proteins in the tubular gland cells of the oviduct to concentrate exogenous proteins in egg white.Type: GrantFiled: August 9, 2002Date of Patent: January 29, 2008Assignee: Origen Therapeutics, Inc.Inventors: Lei Zhu, Peggy Winters-Digiacinto, Robert J. Etches
-
Patent number: 7312374Abstract: This invention provides methods for the stable introduction of heterologous coding sequences into the genome of a bird and expressing the coding sequences to produce desired proteins or to alter the phenotype of the bird. The present invention provides preferred methods for introducing a transgene into the cytoplasm of avian embryonic cells by cytoplasmic microinjection. The embryo then develops into a transgenic adult capable of expressing a heterologous protein and/or capable of generating a line of transgenic birds through breeding. Synthetic vectors and gene promoters useful in the methods are also provided by the present invention, as are transgenic birds that express heterologous protein and avian eggs containing heterologous protein.Type: GrantFiled: September 18, 2002Date of Patent: December 25, 2007Assignee: AviGenics, IncInventors: Jeffrey C. Rapp, Leandro Christmann
-
Patent number: 7237505Abstract: The present invention relates to the field of avian reproduction. In particular, the present invention provides a method of activating an egg in a shell. The invention also provides a method of activating an egg in a shell, whereby a live chick is hatched.Type: GrantFiled: February 15, 2001Date of Patent: July 3, 2007Assignee: Ovo Biosciences, Inc.Inventors: Tim Cantrell, Andrew Wooten
-
Patent number: 7199279Abstract: The invention provides for cells containing nucleic acids which include lysozyme gene expression controlling region nucleotide sequences which typically are linked to a polynucleotide encoding a heterologous polypeptide.Type: GrantFiled: April 1, 2002Date of Patent: April 3, 2007Assignee: AviGenics, Inc.Inventor: Jeffrey C. Rapp
-
Patent number: 7145057Abstract: Sustained cultures of avian embryonic stem cells are provided. Injection of avian embryonic stem cells into recipient embryos yields chimeras with a significant contribution from the embryonic stem cell phenotype. Transgene encoding exogenous proteins are stably integrated in the embryonic stem cells and are present in the somatic tissue of the resulting chimeras. The transgenes may encode exogenous proteins expressed in endodermal, ectodermal, mesodermal, or extra embryonic tissue. Breeding the resulting chimera yields transgenic birds whose genome is comprised of exogenous DNA.Type: GrantFiled: February 1, 2002Date of Patent: December 5, 2006Assignee: Origen Therapeutics, Inc.Inventors: Marie-Cecile Van de Lavoir, Robert J. Etches, Babette Heyer, Jennifer Diamond, Christine Mather, Kathleen Beemer, Heather Myers
-
Patent number: 7129390Abstract: This invention provides vectors and methods for the stable introduction of exogenous nucleic acid sequences into the genome of avians in order to express the exogenous sequences to alter the phenotype of the avians or to produce desired proteins. In particular, transgenic avians are produced which express exogenous sequences in their oviducts and which deposit exogenous proteins into their eggs. Avian eggs that contain exogenous proteins are encompassed by this invention. The instant invention further provides novel forms of interferon and erythropoietin which are efficiently expressed in the oviduct of transgenic avians and deposited into avian eggs.Type: GrantFiled: January 24, 2003Date of Patent: October 31, 2006Assignees: AviGenics, Inc, University of Georgia Research Foundation, Inc.Inventors: Robert D. Ivarie, Alex J. Harvey, Julie A. Morris, Guodong Liu, Jeffrey C. Rapp
-
Patent number: 7041870Abstract: The present invention provides novel transgenic nonhuman mammals capable of producing human sequence antibodies, as well as methods of producing and using these antibodies.Type: GrantFiled: November 30, 2001Date of Patent: May 9, 2006Assignees: Medarex, Inc., Kirin Brewery Company LimitedInventors: Kazuma Tomizuka, Isao Ishida, Nils Lonberg, Edward L. Halk
-
Patent number: 6861572Abstract: Methods for preparing recombinant proteins, such as antibodies, in eggs are described. The method offers advantages over existing systems for preparing recombinant proteins including high yield, low cost and compatibility with animal protection regulations. In addition, since eggs are edible food sources the recombinant protein does not have to be isolated from the egg.Type: GrantFiled: August 21, 1998Date of Patent: March 1, 2005Assignee: Origen Therapeutics, Inc.Inventors: Robert J. Etches, Mansoor Mohammed, Sherie Morrison, Letitia A. Wims, Kham M. Trinh, Alan G. Wildeman
-
Publication number: 20040255345Abstract: The invention provides methods for integrating a heterologous polynucleotide into the genome of an avian cell. The methods deliver to an avian cell a polynucleotide and a source of integrase activity that mediates recombination between the polynucleotide and the genomic DNA of the avian cell. The invention provides modified avian or artificial chromosomes as vectors to shuttle transgenes or gene clusters into an avian genome. Another aspect of the invention are avian cells genetically modified with a transgene vector. One cell line for the delivery and integration of a transgene comprises a heterologous attP site and, optionally, a region for expressing the integrase. Methods are also included for the production of a heterologous polypeptide by transgenic avian tissue involve integrating a heterologous polynucleotide into the avian genome.Type: ApplicationFiled: March 26, 2004Publication date: December 16, 2004Inventors: Jeffrey C. Rapp, Leandro Christmann, Alex J. Harvey, Markley C. Leavitt
-
Publication number: 20040250307Abstract: The present invention provides methods for producing exogenous and chimeric antibodies in avians. One aspect of the present invention is a method of producing avians or avian cells lacking endogenous immunoglobulin light chain and heavy chain loci, or portions thereof, and having at least a portion of at least one exogenous immunoglobulin locus. The present invention provides a method for obtaining an avian cell with a deletion in an endogenous immunoglobulin locus by by introducing a targeting construct comprising two regions of sequences which are homologous to the 5′ and 3′ flanking sequences of the region to be deleted in the wild-type locus. In addition, the invention provides methods for inserting exogenous immunoglobulin gene loci into the genome of an avian cell. A second aspect of the invention is the generation of transgenic avian species or transgenic avian cells for producing chimeric antibodies.Type: ApplicationFiled: December 9, 2003Publication date: December 9, 2004Inventors: Sujay Singh, Peter Dias
-
Publication number: 20040242525Abstract: The present invention provided a method for promoting gonadal growth in an animal, comprising administration of thyroid hormone or its derivatives having thyroid hormone-like activity to the animal. Furthermore, this invention also provided a method for promoting gonadal growth in an animal, comprising introduction of a gene encoding type II deiodinase into the animal, and a transformed animal introduced with a gene encoding type II deiodinase into the animal. The method of the present invention provides a new method for promoting gonadal growth in an animal, through elucidation on the molecular mechanism of photoperiodism (photoperiodic time measurement) in birds.Type: ApplicationFiled: March 24, 2004Publication date: December 2, 2004Applicant: Nagoya UniversityInventors: Takashi Yoshimura, Shizufumi Ebihara
-
Patent number: 6825396Abstract: Vectors and methods are provided for introducing genetic material into cells of a chicken or other avian species. More particularly, vectors and methods are provided for transferring a transgene to an embryonic chicken cell, so as to create a transgenic hen wherein the transgene is expressed in the hen's oviduct and the transgene product is secreted in the hen's eggs and/or those of her offspring. In a preferred embodiment, the transgene product is secreted in the egg white.Type: GrantFiled: April 18, 1997Date of Patent: November 30, 2004Assignee: Board of Trustees Operating Michigan State UniversityInventor: William C. MacArthur
-
Publication number: 20040226057Abstract: The present invention provides for methods of producing a transgenic avians which may include delivering a heterologous nucleic acid to oviduct tissue of an avian wherein the nucleic acid enters a cell of the oviduct tissue and is expressed.Type: ApplicationFiled: May 10, 2004Publication date: November 11, 2004Inventors: Leandro Christmann, Markley C. Leavitt, Dawn M. Eberhardt, Timalynn M. Matthews
-
Publication number: 20040226058Abstract: A culture system for maintaining avian PGCs for long periods in tissue culture is provided. This culture system uses LIF, bFGF, IGF-I and SCF. The resultant PGCs are useful for the production of transgenic and chimeric avians, in particular, chickens or turkeys.Type: ApplicationFiled: June 18, 2004Publication date: November 11, 2004Applicant: University of Massachusetts, a public institution of higher education of the commonwealth of MassachInventors: F. Abel de Leon, Catherine Blackwell, Xiu Ying Gao, James M. Robl, Steven L. Stice, D. Joseph Jerry
-
Publication number: 20040210954Abstract: The invention provides methods forintegrating a heterologous polynucleotide into the genome of an avian cell. The methods deliver to an avian cell a polynucleotide and a source of integrase activity that mediates recombination between the polynucleotide and the genomic DNA of the avian cell. The invention provides modified avian or artificial chromosomes as vectors to shuttle transgenes or gene clusters into an avian genome. Another aspect of the invention are avian cells genetically modified with a transgene vector. One cell line for the delivery and integration of a transgene comprises a heterologous attP site and, optionally, a region for expressing the integrase. Methods are also included for the production of a heterologous polypeptide by transgenic avian tissue involve integrating a heterologous polynucleotide into the avian genome. Subsequently, a mature transgenic avian is derived by transferring the transgenic blastodermal cells to an embryo and allowing that embryo to develop fully.Type: ApplicationFiled: March 1, 2004Publication date: October 21, 2004Inventors: Alex Harvey, Leandro Christmann, Markley C. Leavitt
-
Publication number: 20040172667Abstract: Methods and compositions for the administration of transposon-based vectors to the reproductive organs of animals and the creation of transgenic animals. Preferred methods involve administration of the transposon-based vectors to the lumen of the oviduct of an avian, expression of a vector derived transgene in the avian, and deposition of the resultant polypeptide in an egg. This invention allows for large amounts of protein to be deposited in the egg.Type: ApplicationFiled: December 24, 2003Publication date: September 2, 2004Inventors: Richard K. Cooper, William C. Fioretti, Gary G. Cadd
-
Publication number: 20040172666Abstract: The invention has a object to provide a G0 transgenic chimera bird which can efficiently accumulate the useful protein in eggs of a female bird in which the protein is expressed in an oviduct-specific manner and can accumulate even a toxic protein in eggs with no ill effect for birds, and a transgenic bird and a method of producing them. The above object can be attained by providing a G0 transgenic chimera bird and transgenic bird obtained by introducing a replication-defective retrovirus vector coding for a useful protein by an oviduct-specific expression promoter.Type: ApplicationFiled: August 15, 2003Publication date: September 2, 2004Inventors: Shinji Iijima, Masamichi Kamihira, Kenichi Nishijima, Kenichiro Ono, Kazuhisa Yamaguchi, Shinji Mizuarai
-
Publication number: 20040158880Abstract: The invention provides a novel approach for suppression of endogenous antibody expression in non-human transgenic animals genetically engineered to express one or several human or humanized immunoglobulin transloci. Polyclonal or one or several monoclonal antibodies specific for endogenous IgM and/or IgE heavy and/or light chains are administered to the transgenic animals such that B-cells expressing their endogenous immunoglobulin are depleted and consequently expression of endogenous immunoglobulin is suppressed. Alternatively endogenous immunoglobulin expression may be inhibited through the expression of transgenes encoding such antibodies, including antibody fragments. This method allows the dominant expression of transloci coding for humanized or human antibodies in the blood, milk and eggs of transgenic animals.Type: ApplicationFiled: February 5, 2004Publication date: August 12, 2004Inventors: Roland Buelow, Wim van Schooten
-
Publication number: 20040158882Abstract: This invention provides vectors and methods for the stable introduction of exogenous nucleic acid sequences into the genome of a bird and for expressing said exogenous sequences to alter the phenotype of the bird or to produce desired proteins. In particular, transgenic chickens are produced which express exogenous sequences in their oviducts. Eggs which contain exogenous proteins are also produced.Type: ApplicationFiled: October 28, 2003Publication date: August 12, 2004Applicants: AviGenics, Inc., The University of Georgia Research Foundation, IncInventors: Robert D. Ivarie, Alex J. Harvey, Julie A. Morris, Guodong Liu
-
Publication number: 20040143861Abstract: Methods for preparing cells that contain artificial chromosomes, methods for preparation of artificial chromosomes, methods for purification of artificial chromosomes, methods for targeted insertion of heterologous DNA into artificial chromosomes, and methods for delivery of the chromosomes to selected cells and tissues are provided. Also provided methods for producing transgenic plants and animals using the artificial chromosomes and the resulting transgenic organisms are provided.Type: ApplicationFiled: February 18, 2004Publication date: July 22, 2004Inventors: Gyula Hadlaczky, Aladar A. Szalay
-
Publication number: 20040128705Abstract: The present invention provides transgenic, non-human animals that include a transgene that encodes a fatty acid desaturase, e.g., stearoyl-CoA desaturase, and methods for producing such animals. The invention further provides an expression cassette that includes a coding region for a desaturase such as stearoyl-CoA desaturase, operably linked to a heterologous, tissue-specific animal cell promoter. The invention further provides methods of producing a food product, such as milk, meat, or eggs, using a subject transgenic non-human animal, as well as food products harvested from a subject transgenic non-human animal.Type: ApplicationFiled: September 15, 2003Publication date: July 1, 2004Inventors: James D. Murray, Elizabeth A. Maga
-
Publication number: 20040098756Abstract: The present invention concerns transgenic vertebrates that are useful in expressing proteins and in producing antibodies. The present invention discloses methods for producing vertebrates that are transgenic for a bacteriophage RNA polymerase. The present invention further discloses methods for the use of such transgenic vertebrates in protein expression and in antibody production.Type: ApplicationFiled: October 29, 2003Publication date: May 20, 2004Inventor: Sujay Singh
-
Publication number: 20040088747Abstract: A transgenic non-human animal of the species selected from the group consisting of avian, bovine, ovine and porcine having a transgene which results in disrupting the production of and/or activity of growth differentiation factor-11 (GDF-11) chromosomally integrated into the germ cells of the animal is provided. Also provided are methods for making such animals, and methods of treating animals, including humans, with antibodies or antisense directed to GDF-11. The animals so treated are characterized by increased muscle tissue and bone tissue.Type: ApplicationFiled: June 10, 2003Publication date: May 6, 2004Applicant: THE JOHN HOPKINS UNIVERSITY SCHOOL OF MEDICINEInventors: Se-Jin Lee, Alexandra C. McPherron
-
Patent number: 6730822Abstract: This invention provides vectors and methods for the stable introduction of exogenous nucleic acid sequences into the genome of a bird and for expressing said exogenous sequences to alter the phenotype of the bird or to produce desired proteins. In particular, transgenic chickens are produced which express exogenous sequences in their oviducts. Eggs which contain exogenous proteins are also produced.Type: GrantFiled: October 16, 1998Date of Patent: May 4, 2004Assignee: AviGenics, Inc.Inventors: Robert D. Ivarie, Alex J. Harvey, Julie A. Morris, Guodong Liu, Jeffrey C. Rapp
-
Patent number: 6720473Abstract: A new method for identifying and eliminating chickens that are susceptible to pulmonary hypertension uses micrometer scale particles to occlude blood vessels in the lungs of the chickens. This results in the death of chickens that are pre-disposed to pulmonary hypertension. The invention effectively culls a chicken stock of the weaker animals.Type: GrantFiled: August 13, 2001Date of Patent: April 13, 2004Assignee: University of ArkansasInventors: Gisela F. Erf, Robert F. Wideman, Jr., Howard L. French
-
Publication number: 20040040048Abstract: The present invention provides an isolated animal cell comprising an exogenous nucleic acid encoding a mutated phytase, wherein the cell produces phytase and secretes the phytase from the cell. The present invention also provides an animal having a phenotype not naturally occurring, characterized by secretion of phytase into the lumen of the gastrointestinal tract of the animal, the phenotype being conferred by a transgene contained in the cells of the animal, the transgene comprising a nucleic acid sequence encoding phytase and methods of making said animal.Type: ApplicationFiled: July 3, 2003Publication date: February 26, 2004Inventors: Stephen Shears, Paul R. Reynolds, James N. Petitte